| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/17/2009 | US7504390 Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 03/17/2009 | US7504389 Protein tyrosine phosphatase inhibitors and methods of use thereof |
| 03/17/2009 | US7504388 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 03/17/2009 | US7504387 Bone disorders; antiinflammatory agents; antiarthritic agents; mixture of chondroitin sulfate, n-acetylglucosamine and hyaluronic acid |
| 03/17/2009 | US7504386 comprised of benzyl esters of hyaluronic acid and/or internally cross-linked derivatives of hyaluronic acid and may be in the form of gels, membranes, woven tissues or meshes and nonwoven tissues; adhesion prevention |
| 03/17/2009 | US7504384 Use of lipid conjugates in the treatment of infection |
| 03/17/2009 | US7504378 Viricides; induction immunology response; compounds according to invention specifically inhibit NS3 protease and do not show significant inhibitory activity against other serine proteases such as human leukocyte elastase, porcine pancreatic elastase, bovine pancreatic chymotrypsin, or cysteine proteases |
| 03/17/2009 | US7504376 administering a beta-alanylhistidine dipeptide and a glycine, an insulin, an insulin mimic, or an insulin-action modifier to increase blood plasma concentrations of beta-alanine and/or creatine; dietary supplements and sports drinks. |
| 03/17/2009 | US7504362 Pesticidal compositions |
| 03/17/2009 | US7504246 Hyaluronan synthase gene and uses thereof |
| 03/17/2009 | US7504243 Methods for the production of biliverdin |
| 03/17/2009 | US7504231 Sustained release; synergistic mixture of inhibition of neurotransmitter synthesis and analgesics |
| 03/17/2009 | US7504228 Integrin linked kinase modulation of monocyte activation |
| 03/17/2009 | US7504226 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 03/17/2009 | US7504212 Cancer monitoring and therapeutics |
| 03/17/2009 | US7504118 cinnamon, or an extract of cinnamon, and creatine, or a derivative or a precursor thereof; enhancing athletic performance |
| 03/17/2009 | US7504113 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 03/17/2009 | US7504111 Protein from gonococcus (Neisseria gonorrhoeae), including a specific amino acid sequence; antigens for vaccines, immunogenic compositions, and/or diagnostics; useful for distinguishing between gonococcus and meningococcus |
| 03/17/2009 | US7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore |
| 03/17/2009 | US7504095 2,10-dioxo,2,12,12-trihydroxy,8-amino-4,4a,5a,6,9,10,11,11a,12,12a-decahydropterino(6',7':5,6)pyrano(2,3-d)-1,3,2-dioxaphosphorin |
| 03/17/2009 | US7503913 Methods and compositions for use in perfusion applications |
| 03/17/2009 | CA2639658A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2429263C Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2380205C Novel bicyclonucleoside analogues |
| 03/17/2009 | CA2374333C Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract |
| 03/17/2009 | CA2360668C The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 03/17/2009 | CA2359116C Substituted porphyrins |
| 03/17/2009 | CA2355712C Antiviral nucleoside analogues |
| 03/17/2009 | CA2347925C Propofol composition |
| 03/17/2009 | CA2346863C Therapeutic use of polymers |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2339283C A process for the preparation of zofenopril calcium salt |
| 03/17/2009 | CA2338638C Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| 03/17/2009 | CA2337849C Piperazinone derivatives and applications thereof |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/17/2009 | CA2309159C Skin penetration enhancing components |
| 03/17/2009 | CA2258882C Compositions and methods for altering the biodistribution of biological agents |
| 03/17/2009 | CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 03/17/2009 | CA2192438C Novel composition stimulating the cerebral activity and based on alkaloids having an eburnamenine nucleus, and preparation methods |
| 03/17/2009 | CA2179407C Process for the preparation of leukotriene antagonists |
| 03/17/2009 | CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/12/2009 | WO2009033183A2 Compounds and methods for treatment of hcv and conditions associated with cd81 binding |
| 03/12/2009 | WO2009033175A1 Animal parasite-control method using insect growth regulators |
| 03/12/2009 | WO2009033165A1 Hypoxia activated prodrugs of bis-alkylating agents |
| 03/12/2009 | WO2009033140A1 Microrna signatures in human ovarian cancer |
| 03/12/2009 | WO2009033131A2 Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin |
| 03/12/2009 | WO2009033130A1 Mitochondrial compositions and uses thereof |
| 03/12/2009 | WO2009033125A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 03/12/2009 | WO2009033094A2 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | WO2009033091A1 Treatment of th17-mediated autoimmune disease via inhibition of stat3 |
| 03/12/2009 | WO2009033084A1 Pyrazolo-pyridines as tyrosine kinase inhibitors |
| 03/12/2009 | WO2009033079A1 Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033078A2 Compositions and methods for controlling cholesterol levels |
| 03/12/2009 | WO2009033069A1 Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033061A1 Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033054A1 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033047A2 Methods and compositions for treating diseases and conditions involving higher molecular weight hyaluronan |
| 03/12/2009 | WO2009033039A2 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 03/12/2009 | WO2009032972A1 Compositions and methods for treating immunological and inflammatory diseases and disorders |
| 03/12/2009 | WO2009032955A1 Dheas inhalation compositions |
| 03/12/2009 | WO2009032930A2 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof |
| 03/12/2009 | WO2009032888A2 Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract |
| 03/12/2009 | WO2009032887A1 Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 03/12/2009 | WO2009032885A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 03/12/2009 | WO2009032870A2 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration |
| 03/12/2009 | WO2009032861A1 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 03/12/2009 | WO2009032840A1 Fluorine- substituted 2 ', 6 ' -dimethyl-l-tyrosine-1, 2,3, 4-tetrahydr0is0quin0line-3-carb0xylic acid peptides (dmt-tic) for use as myu- and delta-opioid receptor probes in |
| 03/12/2009 | WO2009032779A2 Methods and compositions for the size-specific seperation of nucleic acid from a sample |
| 03/12/2009 | WO2009032764A1 Acetamide stereoisomer |
| 03/12/2009 | WO2009032754A2 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 03/12/2009 | WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors |
| 03/12/2009 | WO2009032699A1 Anti-proliferative combinations |
| 03/12/2009 | WO2009032694A1 Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis |
| 03/12/2009 | WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 03/12/2009 | WO2009032667A1 Thiazole and oxazole kinase inhibitors |
| 03/12/2009 | WO2009032653A1 Inhibitors of akt activity |
| 03/12/2009 | WO2009032652A1 Inhibitors of akt activity |
| 03/12/2009 | WO2009032651A1 Inhibitors of akt activity |
| 03/12/2009 | WO2009032600A1 7-keto dhea for psychiatric use |
| 03/12/2009 | WO2009032558A2 Preparation of ziprasidone hydrochloride monohydrate |
| 03/12/2009 | WO2009032538A1 Method of preventing nephrocalcinosis |
| 03/12/2009 | WO2009032406A1 Dentifrice compositions for treating xerostomia |
| 03/12/2009 | WO2009032326A1 New tetracycline derivatives as antiinfective agents |
| 03/12/2009 | WO2009032321A2 A method for treating diabetes |
| 03/12/2009 | WO2009032276A1 Meat tenderness using beta-agonists |
| 03/12/2009 | WO2009032273A1 Method of treating glaucoma using rasagiline |
| 03/12/2009 | WO2009032268A1 Azithromycin for treatment of skin disorders |
| 03/12/2009 | WO2009032267A2 Contact lens based bioactive agent delivery system |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009032246A2 Particulate compositions for delivery of poorly soluble drugs |
| 03/12/2009 | WO2009032244A1 Method for the treatment of hiv/aids infection using acyclovir in identified subjects |
| 03/12/2009 | WO2009032223A1 Improved brimonidine compositions for treating erythema |
| 03/12/2009 | WO2009032203A1 Colloidal metal-containing skin sanitizer |
| 03/12/2009 | WO2009032202A1 Treatment of brain disorders |
| 03/12/2009 | WO2009032198A1 Co-crystals and pharmaceutical compositions comprising the same |
| 03/12/2009 | WO2009032180A1 Phosphadiazine hcv polymerase inhibitors iv |